Streetbeat News

Price Targets

NPCE

Wall Street analysts have set a mean price target for NeuroPace (NPCE) that suggests a potential 54.3% upside. Despite the mixed reliability of price targets, the consensus among analysts in raising earnings estimates supports a positive outlook for NPCE.

Portfolio Pulse from

November 18, 2024 | 4:15 pm

ADMA

Wall Street analysts predict a 31.3% upside for Adma Biologics (ADMA) based on average price targets. Positive earnings estimate revisions could support this potential increase.

Portfolio Pulse from

November 18, 2024 | 4:15 pm

BTMD

Wall Street analysts predict a 77% upside for biote Corp. (BTMD) based on average price targets. Positive earnings estimate revisions could support this potential increase.

Portfolio Pulse from

November 18, 2024 | 4:15 pm

SRTS

Wall Street analysts predict a 39.66% upside for Sensus Healthcare (SRTS) based on the mean of price targets. Despite the historical inaccuracy of this metric, the consensus on raising earnings estimates suggests potential growth.

Portfolio Pulse from

November 18, 2024 | 4:15 pm

SMCI

Super Micro Computer (SMCI) has experienced a 70% stock dip over the past three months. Despite this, the company's long-term growth potential and low valuation suggest it may be a good buying opportunity.

Portfolio Pulse from

November 18, 2024 | 3:00 pm

LTM

LATAM Airlines has emerged from bankruptcy with strong financial performance, including a 14% operating margin and significant income growth. The company has refinanced its debt, reducing interest expenses, and projects substantial free cash flows. Analysts forecast continued growth, supporting a potential 80% upside in stock price.

Portfolio Pulse from

November 18, 2024 | 11:30 am

KNBHF

Knorr-Bremse, despite challenges in the trucking sector, remains a solid investment with strong fundamentals. The company's railway segment shows strong growth, supporting a positive long-term investment thesis. The price target has been revised to €95/share.

Portfolio Pulse from

November 18, 2024 | 9:45 am

DUAVF

Dassault Aviation experienced a 21% EBITDA growth due to strong jet demand, but its stock underperformed compared to the S&P 500 due to past weak performance and supply chain issues. Despite being slightly overvalued, it remains a buy with a $214.50 price target.

Portfolio Pulse from

November 17, 2024 | 5:45 pm

ECL

Ecolab reported strong Q3 results with 4% organic revenue growth and 22% adjusted operating profit growth. Despite this, the stock is considered overvalued with a 'Sell' rating and a fair value of $220 per share. Growth is driven by value-based pricing and innovative products, but cost pressures and competition are risks.

Portfolio Pulse from

November 17, 2024 | 2:00 pm

OMAB

Grupo Aeroportuario del Centro Norte's Q3 results exceeded expectations with a 1.4% revenue increase, driven by non-aeronautical revenues. Despite higher concession taxes impacting margins, the stock is still rated a buy with a 48% upside potential and a price target of $93.60.

Portfolio Pulse from

November 17, 2024 | 1:15 pm